Bleichroeder LP
Long book
$578.6M
Q1 2026
Positions
81
Top-10 weight
80%
concentration
Last quarter
-1.5%
SPY +14.8%
Turnover
23%
of book per quarter
Strategy in plain words
auto-generated from filingsBleichroeder LP is an institutional manager, specialised in financials (66% of the long book), running a $578.6M US long book across 81 positions.
The portfolio is extremely concentrated — the top 10 positions are almost the whole book. Turnover is modest: positions are typically held for years. Current anchor positions: SPDR GOLD SHARES, GPGI INC, RESOLUTE HOLDINGS MANAG, SS SPDR S&P 500 ETF TRUST-US, LINDE PLC.
Over the last 9 quarters its long book ran on average 2.5pp per quarter ahead of the S&P 500, beating the index in 6 of 9 quarters. Signal value of individual moves is limited — treat changes as weak evidence.
Implied long-book return vs S&P 500
methodology: positions priced quarterly, no shorts/options Fund long book S&P 500
Q1 2024
-2.3%
Q2 2024
+17.0%
Q3 2024
+6.9%
Q4 2024
+0.7%
Q1 2025
+10.7%
Q2 2025
+21.6%
Q3 2025
+12.7%
Q4 2025
-2.8%
Q1 2026
-1.5%
Sector allocation
Financials 43%
Healthcare 17%
Technology 14%
Materials 11%
Other 6%
Services media 5%
Industrials 2%
Consumer staples 1%
Long book by quarter
What does Bleichroeder LP own?
Q1 2026 13F| Company | Sector | Shares | Value | % of book | Change |
|---|---|---|---|---|---|
| GPGI GPGI INC | Financials | 4.0M | $67.9M | 11.7% | -0.1% |
| RHLD RESOLUTE HOLDINGS MANAG | Financials | 314.2K | $51.0M | 8.8% | -1.8% |
| LIN LINDE PLC | Materials | 68.5K | $33.9M | 5.9% | -8.8% |
| O6C1 MDXHEALTH | — | 7.4M | $17.0M | 2.9% | Held |
| IDN INTELLICHECK INC | Technology | 2.1M | $14.5M | 2.5% | Held |
| DUOT DUOS TECHNOLOGIES GROUP INC | Technology | 1.6M | $11.2M | 1.9% | Held |
| INVE IDENTIV INC | Technology | 2.9M | $10.7M | 1.8% | Held |
| BX BLACKSTONE INC | Financials | 90.8K | $10.4M | 1.8% | Held |
| DTIL PRECISION BIOSCIENCES INC | Healthcare | 1.7M | $9.1M | 1.6% | Held |
| IMMX IMMIX BIOPHARMA INC | Healthcare | 1.0M | $9.1M | 1.6% | Held |
| SPGI S&P GLOBAL INC | Services media | 20.0K | $8.5M | 1.5% | Held |
| LIQT LIQTECH INTERNATIONAL INC | Industrials | 3.2M | $6.1M | 1.1% | Held |
| FLNT FLUENT INC | Services media | 1.4M | $4.5M | 0.8% | Held |
| JPM JPMORGAN CHASE & CO | Financials | 15.0K | $4.4M | 0.8% | Held |
| COCH ENVOY MEDICAL INC | Healthcare | 6.3M | $4.2M | 0.7% | New |
| EYPT EYEPOINT INC | Healthcare | 316.5K | $4.1M | 0.7% | Held |
| BRFH BARFRESH FOOD GROUP INC | Consumer staples | 1.4M | $3.9M | 0.7% | Held |
| PROK PROKIDNEY CORP | Healthcare | 2.0M | $3.6M | 0.6% | Held |
| ROC RANK ONE COMPUTING CORP | Technology | 500.0K | $3.5M | 0.6% | New |
| IRD OPUS GENETICS INC | Healthcare | 736.8K | $3.4M | 0.6% | Held |
| GNLX GENELUX CORP | Healthcare | 1.4M | $3.3M | 0.6% | +93.4% |
| DMAC DIAMEDICA THERAPEUTICS INC | Healthcare | 382.3K | $2.6M | 0.4% | Held |
| CRIS CURIS INC | Healthcare | 3.8M | $2.1M | 0.4% | +234.8% |
| VENU VENU HOLDING CORP | Services media | 600.0K | $2.0M | 0.3% | +200.0% |
| RNXT RENOVORX INC | Healthcare | 1.7M | $1.7M | 0.3% | +177.7% |
| PROF PROFOUND MEDICAL CORP | Healthcare | 254.8K | $1.7M | 0.3% | Held |
| CUE CUE BIOPHARMA INC | Healthcare | 6.8M | $1.6M | 0.3% | Held |
| CGEM CULLINAN THERAPEUTICS INC | Healthcare | 100.0K | $1.4M | 0.2% | New |
| POCI PRECISION OPTICS CORP INC | Healthcare | 270.9K | $1.2M | 0.2% | +23.0% |
| LLYVK LIBERTY LIVE HOLDINGS-C | Services media | 13.8K | $1.2M | 0.2% | Held |
| RTX RTX CORP | Industrials | 6.0K | $1.2M | 0.2% | Held |
| PXLW PIXELWORKS INC | Technology | 201.0K | $1.1M | 0.2% | Held |
| MODD MODULAR MEDICAL INC | Healthcare | 187.0K | $987K | 0.2% | New |
| QTI QT IMAGING HOLDINGS INC | Healthcare | 166.7K | $978K | 0.2% | New |
| TLPH TALPHERA INC | Healthcare | 1.3M | $977K | 0.2% | +48.4% |
| OWLT OWLET INC | Other | 172.0K | $884K | 0.2% | -44.5% |
| IPWR IDEAL POWER INC | Technology | 300.0K | $849K | 0.1% | +125.6% |
| FEAM 5E ADVANCED MATERIALS INC | Materials | 500.0K | $700K | 0.1% | New |
| MAIA MAIA BIOTECHNOLOGY INC | Healthcare | 500.0K | $700K | 0.1% | New |
| ICCC IMMUCELL CORP | Materials | 101.6K | $643K | 0.1% | Held |
| SHAZ SHARONAI HOLDINGS INC | Technology | 25.0K | $568K | 0.1% | New |
| LHX L3HARRIS TECHNOLOGIES INC | Technology | 1.6K | $552K | 0.1% | Held |
| LLYVA LIBERTY LIVE HOLDINGS-A | Services media | 6.0K | $502K | 0.1% | Held |
| CARR CARRIER GLOBAL CORP | Industrials | 6.0K | $338K | 0.1% | Held |
| CLRB CELLECTAR BIOSCIENCES INC | Healthcare | 100.0K | $254K | 0.0% | Held |
| PYPL PAYPAL HOLDINGS INC | Services media | 5.3K | $240K | 0.0% | Held |
| BNY BANK OF NEW YORK MELLON CORP | Financials | 2.0K | $237K | 0.0% | Held |
| OTIS OTIS WORLDWIDE CORP | Industrials | 3.0K | $231K | 0.0% | Held |
| TMDX TRANSMEDICS GROUP INC | Healthcare | 2.1K | $209K | 0.0% | Held |
| NSRX NASUS PHARMA LTD | Healthcare | 89.8K | $199K | 0.0% | New |
13F filing history
| Period | Form | Filed | Entries | Reported value | Flags | Source |
|---|---|---|---|---|---|---|
| Q1 2026 | 13F-HR | May 14, 2026 | 81 | $578.6M | canonical | SEC ↗ |
| Q4 2025 | 13F-HR | Feb 13, 2026 | 73 | $568.3M | canonical | SEC ↗ |
| Q3 2025 | 13F-HR | Nov 14, 2025 | 72 | $513.0M | canonical | SEC ↗ |
| Q2 2025 | 13F-HR | Aug 14, 2025 | 76 | $406.8M | canonical | SEC ↗ |
| Q1 2025 | 13F-HR | May 15, 2025 | 78 | $375.3M | canonical | SEC ↗ |
| Q4 2024 | 13F-HR | Feb 14, 2025 | 74 | $397.9M | canonical | SEC ↗ |
| Q3 2024 | 13F-HR | Nov 13, 2024 | 73 | $371.6M | canonical | SEC ↗ |
| Q2 2024 | 13F-HR | Aug 13, 2024 | 75 | $336.2M | canonical | SEC ↗ |
| Q1 2024 | 13F-HR | May 14, 2024 | 80 | $400.9M | canonical | SEC ↗ |